This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07599/identifier/chemspider/
n6http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n11http://linked.opendata.cz/resource/drugbank/drug/DB07599/identifier/pdb/
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n8http://linked.opendata.cz/resource/drugbank/drug/DB07599/identifier/pubchem-compound/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n9http://linked.opendata.cz/resource/drugbank/drug/DB07599/identifier/pubchem-substance/
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07599/identifier/drugbank/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07599
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB07599 n13:DB07599
dcterms:title
[(2-AMINO-ALPHA-METHOXYIMINO-4-THIAZOLYLACETYL)AMINO]METHYLBORONIC ACID
adms:identifier
n8:9600412 n9:99444070 n10:DB07599 n11:CXB n14:7874552
n3:IUPAC-Name
n4:271B540C-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5412-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5411-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B540E-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B540F-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5410-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B540A-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B540B-363D-11E5-9242-09173F13E4C5 n4:271B5408-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5409-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5418-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5419-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5413-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5414-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5416-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5415-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5417-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B541E-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5420-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5421-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B541D-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B541C-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B541F-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B540D-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B541A-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B541B-363D-11E5-9242-09173F13E4C5